Alfredo Pascual headshot
EMAIL: [email protected]
PHONE: 720.213.5971

Alfredo Pascual

Based in Germany, Alfredo specializes in international cannabis markets and regulations, drawing upon his extensive academic background in business and public policy. He founded Transnational Cannabis, a consultancy firm that focused on cannabis regulatory frameworks in Europe and Latin America. Previously, he did business development for ICC Labs with a primary focus on developing expansion opportunities internationally.

Germany’s first medical cannabis harvests likely delayed until 2021

Germany’s first domestic harvests of medical cannabis flower – originally expected to occur by November – could be delayed because of the COVID-19 pandemic, according to a government reply to a parliamentary query. “It cannot be ruled out that the persistent consequences of the COVID-19 pandemic in many economic sectors could have a time-delaying effect […]

Read More

Macedonian medical cannabis could soon be available in Germany, Poland

PharmaCann Polska recently became the first company to obtain EU-Good Manufacturing Practice (EU-GMP) certification to produce medical cannabis extracts at its facility in North Macedonia, according to its CEO. That brings the Warsaw-headquartered company – along with its production facilities in North Macedonia – one step closer to being able to offer its medical cannabis […]

Read More

Supply of medical cannabis restored in Malta after shortage

After a weekslong shortage of high-THC medical cannabis flower in Malta, at least one variety became available again as of Sept. 4, Marijuana Business Daily has confirmed. “Thankfully, one of the only two locally licensed brands, Bedrocan, made it to the pharmacies last Friday, while Pedanios should be in stock soon,” Andrew Bonello, president of […]

Read More

German group rejects CBD narcotic classification, wants sales only via prescription

An association of pharmacies dispensing medical cannabis in Germany spurned the idea that CBD ought to be considered a narcotic but wants the cannabinoid to remain available only via prescription. The German Association for Cannabis Dispensing Pharmacies said in a news release that “CBD is an important ingredient of the cannabis plant, which both influences the […]

Read More

Chile health authority warns of ‘counterfeit’ cannabis medicines

The Public Health Institute of Chile (ISP) issued a warning recently about CBD products offered for sale online without a required sanitary registration. Many CBD products “suddenly disappeared” from the market after the ISP news release, local sources told Marijuana Business Daily. In recent months, the gray market had expanded considerably, according MJBizDaily’s second edition […]

Read More

Clever Leaves obtains cannabis cultivation license in Portugal

Clever Leaves, a multinational cannabis company with its main operations in Colombia, said Thursday it obtained a “license to cultivate, sell and export medical cannabis” in Portugal. Clever Leaves said the license it received from Infarmed – the Portuguese health authority – is “provisional” because the facility has not been physically inspected because of the […]

Read More

More Tilray cannabis product recalls in Germany, report says

British Columbia, Canada-based Tilray is recalling new batches of medical cannabis extracts in Germany because of incorrect THC content, German independent pharmaceutical newspaper DAZ reported. It is the second recall of Tilray products in Germany this summer. According to DAZ, Tilray recalled a total of six batches of the same product: THC10:CBD10. The extract is a […]

Read More

Cansativa chosen as sole distributor of German-grown cannabis

Mörfelden-Walldorf-based Cansativa won the German distribution tender, becoming the sole distributor of all cannabis that will be grown in Germany for medical purposes during the next four years, the company announced in a news release. The company, located in the Frankfurt Rhine-Main Region, will provide logistics, wholesale and distribution services to the German Federal Institute […]

Read More

Uruguay approves new rules to facilitate exports, spur cannabis industry

Uruguayan President Lacalle Pou signed two decrees with the aim of spurring development of the medical marijuana and hemp industries and encouraging exports, Deputy Secretary of the Presidency Rodrigo Ferrés said during a news conference late last week. The new rules simplify the export process of medical cannabis. One decree allows businesses to export psychoactive […]

Read More

Polish authorities detain cannabis industry executive and regulator

A cannabis industry executive and a Polish government official in charge of the office responsible for registering medical products were detained by the Central Anti-Corruption Bureau (CBA), the government office communicated Friday. The two individuals were detained in a restaurant after allegedly concluding an agreement to “arrange” the registration of a medical cannabis product. CBA […]

Read More

Tilray recalls ‘select batches’ of cannabis extracts in Germany

British Columbia, Canada-based Tilray is recalling a small amount of medical cannabis in Germany because of incorrect THC content, German independent pharmaceutical newspaper DAZ reported. The product is THC10:CBD10,  a full-spectrum oil with 10 milligrams per milliliter of THC and 10 milligrams per milliliter of CBD. “Tilray has initiated a voluntary recall of select batches […]

Read More